Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice

Kollmann K, Damme M, Markmann S, Morelle W, Schweizer M, Hermans-Borgmeyer I, Rochert AK, Pohl S, Lübke T, Michalski J-C, Kakela R, et al. (2012)
Brain 135(9): 2661-2675.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Kollmann, K; Damme, MarkusUniBi; Markmann, S; Morelle, W; Schweizer, M; Hermans-Borgmeyer, I; Rochert, A K; Pohl, S; Lübke, TorbenUniBi ; Michalski, J-C; Kakela, R; Walkley, S U
Abstract / Bemerkung
Mucolipidosis II is a neurometabolic lysosomal trafficking disorder of infancy caused by loss of mannose 6-phosphate targeting signals on lysosomal proteins, leading to lysosomal dysfunction and accumulation of non-degraded material. However, the identity of storage material and mechanisms of neurodegeneration in mucolipidosis II are unknown. We have generated 'knock-in' mice with a common mucolipidosis II patient mutation that show growth retardation, progressive brain atrophy, skeletal abnormalities, elevated lysosomal enzyme activities in serum, lysosomal storage in fibroblasts and brain and premature death, closely mimicking the mucolipidosis II disease in humans. The examination of affected mouse brains at different ages by immunohistochemistry, ultrastructural analysis, immunoblotting and mass spectrometric analyses of glycans and anionic lipids revealed that the expression and proteolytic processing of distinct lysosomal proteins such as alpha-l-fucosidase, beta-hexosaminidase, alpha-mannosidase or Niemann-Pick C2 protein are more significantly impacted by the loss of mannose 6-phosphate residues than enzymes reaching lysosomes independently of this targeting mechanism. As a consequence, fucosylated N-glycans, GM2 and GM3 gangliosides, cholesterol and bis(monoacylglycero)phosphate accumulate progressively in the brain of mucolipidosis II mice. Prominent astrogliosis and the accumulation of organelles and storage material in focally swollen axons were observed in the cerebellum and were accompanied by a loss of Purkinje cells. Moreover, an increased neuronal level of the microtubule-associated protein 1 light chain 3 and the formation of p62-positive neuronal aggregates indicate an impairment of constitutive autophagy in the mucolipidosis II brain. Our findings demonstrate the essential role of mannose 6-phosphate for selected lysosomal proteins to maintain the capability for degradation of sequestered components in lysosomes and autophagolysosomes and prevent neurodegeneration. These lysosomal proteins might be a potential target for a valid therapeutic approach for mucolipidosis II disease.
Page URI


Kollmann K, Damme M, Markmann S, et al. Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice. Brain. 2012;135(9):2661-2675.
Kollmann, K., Damme, M., Markmann, S., Morelle, W., Schweizer, M., Hermans-Borgmeyer, I., Rochert, A. K., et al. (2012). Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice. Brain, 135(9), 2661-2675. doi:10.1093/brain/aws209
Kollmann, K, Damme, Markus, Markmann, S, Morelle, W, Schweizer, M, Hermans-Borgmeyer, I, Rochert, A K, et al. 2012. “Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice”. Brain 135 (9): 2661-2675.
Kollmann, K., Damme, M., Markmann, S., Morelle, W., Schweizer, M., Hermans-Borgmeyer, I., Rochert, A. K., Pohl, S., Lübke, T., Michalski, J. - C., et al. (2012). Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice. Brain 135, 2661-2675.
Kollmann, K., et al., 2012. Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice. Brain, 135(9), p 2661-2675.
K. Kollmann, et al., “Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice”, Brain, vol. 135, 2012, pp. 2661-2675.
Kollmann, K., Damme, M., Markmann, S., Morelle, W., Schweizer, M., Hermans-Borgmeyer, I., Rochert, A.K., Pohl, S., Lübke, T., Michalski, J.-C., Kakela, R., Walkley, S.U., Braulke, T.: Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice. Brain. 135, 2661-2675 (2012).
Kollmann, K, Damme, Markus, Markmann, S, Morelle, W, Schweizer, M, Hermans-Borgmeyer, I, Rochert, A K, Pohl, S, Lübke, Torben, Michalski, J-C, Kakela, R, Walkley, S U, and Braulke, T. “Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice”. Brain 135.9 (2012): 2661-2675.

37 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Lipid-induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders.
Gabandé-Rodríguez E, Pérez-Cañamás A, Soto-Huelin B, Mitroi DN, Sánchez-Redondo S, Martínez-Sáez E, Venero C, Peinado H, Ledesma MD., EMBO J 38(2), 2019
PMID: 30530526
Lysosomes and Brain Health.
Sharma J, di Ronza A, Lotfi P, Sardiello M., Annu Rev Neurosci 41(), 2018
PMID: 29661037
Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation.
Danyukova T, Ariunbat K, Thelen M, Brocke-Ahmadinejad N, Mole SE, Storch S., Hum Mol Genet 27(10), 2018
PMID: 29514215
Lysosomal Proteome and Secretome Analysis Identifies Missorted Enzymes and Their Nondegraded Substrates in Mucolipidosis III Mouse Cells.
Di Lorenzo G, Velho RV, Winter D, Thelen M, Ahmadi S, Schweizer M, De Pace R, Cornils K, Yorgan TA, Grüb S, Hermans-Borgmeyer I, Schinke T, Müller-Loennies S, Braulke T, Pohl S., Mol Cell Proteomics 17(8), 2018
PMID: 29773673
Site-1 protease deficiency causes human skeletal dysplasia due to defective inter-organelle protein trafficking.
Kondo Y, Fu J, Wang H, Hoover C, McDaniel JM, Steet R, Patra D, Song J, Pollard L, Cathey S, Yago T, Wiley G, Macwana S, Guthridge J, McGee S, Li S, Griffin C, Furukawa K, James JA, Ruan C, McEver RP, Wierenga KJ, Gaffney PM, Xia L., JCI Insight 3(14), 2018
PMID: 30046013
The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover.
Pohl S, Angermann A, Jeschke A, Hendrickx G, Yorgan TA, Makrypidi-Fraune G, Steigert A, Kuehn SC, Rolvien T, Schweizer M, Koehne T, Neven M, Winter O, Velho RV, Albers J, Streichert T, Pestka JM, Baldauf C, Breyer S, Stuecker R, Muschol N, Cox TM, Saftig P, Paganini C, Rossi A, Amling M, Braulke T, Schinke T., J Bone Miner Res 33(12), 2018
PMID: 30075049
Mn Inhibits GSH Synthesis via Downregulation of Neuronal EAAC1 and Astrocytic xCT to Cause Oxidative Damage in the Striatum of Mice.
Yang X, Yang H, Wu F, Qi Z, Li J, Xu B, Liu W, Xu Z, Deng Y., Oxid Med Cell Longev 2018(), 2018
PMID: 30228854
Quantitative Proteome Analysis of Mouse Liver Lysosomes Provides Evidence for Mannose 6-phosphate-independent Targeting Mechanisms of Acid Hydrolases in Mucolipidosis II.
Markmann S, Krambeck S, Hughes CJ, Mirzaian M, Aerts JM, Saftig P, Schweizer M, Vissers JP, Braulke T, Damme M., Mol Cell Proteomics 16(3), 2017
PMID: 28062798
Spermine synthase deficiency causes lysosomal dysfunction and oxidative stress in models of Snyder-Robinson syndrome.
Li C, Brazill JM, Liu S, Bello C, Zhu Y, Morimoto M, Cascio L, Pauly R, Diaz-Perez Z, Malicdan MCV, Wang H, Boccuto L, Schwartz CE, Gahl WA, Boerkoel CF, Zhai RG., Nat Commun 8(1), 2017
PMID: 29097652
Lysosomal dysfunction and impaired autophagy in a novel mouse model deficient for the lysosomal membrane protein Cln7.
Brandenstein L, Schweizer M, Sedlacik J, Fiehler J, Storch S., Hum Mol Genet 25(4), 2016
PMID: 26681805
Cathepsin D and its newly identified transport receptor SEZ6L2 can modulate neurite outgrowth.
Boonen M, Staudt C, Gilis F, Oorschot V, Klumperman J, Jadot M., J Cell Sci 129(3), 2016
PMID: 26698217
A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease.
Wolf H, Damme M, Stroobants S, D'Hooge R, Beck HC, Hermans-Borgmeyer I, Lüllmann-Rauch R, Dierks T, Lübke T., Dis Model Mech 9(9), 2016
PMID: 27491075
Subcellular Trafficking of Mammalian Lysosomal Proteins: An Extended View.
Staudt C, Puissant E, Boonen M., Int J Mol Sci 18(1), 2016
PMID: 28036022
Autophagy in neuronal cells: general principles and physiological and pathological functions.
Damme M, Suntio T, Saftig P, Eskelinen EL., Acta Neuropathol 129(3), 2015
PMID: 25367385
Mannose 6 phosphorylation of lysosomal enzymes controls B cell functions.
Otomo T, Schweizer M, Kollmann K, Schumacher V, Muschol N, Tolosa E, Mittrücker HW, Braulke T., J Cell Biol 208(2), 2015
PMID: 25601403
Lrp1/LDL Receptor Play Critical Roles in Mannose 6-Phosphate-Independent Lysosomal Enzyme Targeting.
Markmann S, Thelen M, Cornils K, Schweizer M, Brocke-Ahmadinejad N, Willnow T, Heeren J, Gieselmann V, Braulke T, Kollmann K., Traffic 16(7), 2015
PMID: 25786328
Site-1 protease-activated formation of lysosomal targeting motifs is independent of the lipogenic transcription control.
Klünder S, Heeren J, Markmann S, Santer R, Braulke T, Pohl S., J Lipid Res 56(8), 2015
PMID: 26108224
In Vivo Evidence for Lysosome Depletion and Impaired Autophagic Clearance in Hereditary Spastic Paraplegia Type SPG11.
Varga RE, Khundadze M, Damme M, Nietzsche S, Hoffmann B, Stauber T, Koch N, Hennings JC, Franzka P, Huebner AK, Kessels MM, Biskup C, Jentsch TJ, Qualmann B, Braulke T, Kurth I, Beetz C, Hübner CA., PLoS Genet 11(8), 2015
PMID: 26284655
Mannose 6-phosphate-independent Lysosomal Sorting of LIMP-2.
Blanz J, Zunke F, Markmann S, Damme M, Braulke T, Saftig P, Schwake M., Traffic 16(10), 2015
PMID: 26219725
Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I.
Kuehn SC, Koehne T, Cornils K, Markmann S, Riedel C, Pestka JM, Schweizer M, Baldauf C, Yorgan TA, Krause M, Keller J, Neven M, Breyer S, Stuecker R, Muschol N, Busse B, Braulke T, Fehse B, Amling M, Schinke T., Hum Mol Genet 24(24), 2015
PMID: 26427607
Myopathy in Marinesco-Sjögren syndrome links endoplasmic reticulum chaperone dysfunction to nuclear envelope pathology.
Roos A, Buchkremer S, Kollipara L, Labisch T, Gatz C, Zitzelsberger M, Brauers E, Nolte K, Schröder JM, Kirschner J, Jesse CM, Goebel HH, Goswami A, Zimmermann R, Zahedi RP, Senderek J, Weis J., Acta Neuropathol 127(5), 2014
PMID: 24362440
Gene disruption of Mfsd8 in mice provides the first animal model for CLN7 disease.
Damme M, Brandenstein L, Fehr S, Jankowiak W, Bartsch U, Schweizer M, Hermans-Borgmeyer I, Storch S., Neurobiol Dis 65(), 2014
PMID: 24423645
Mucolipidosis II-related mutations inhibit the exit from the endoplasmic reticulum and proteolytic cleavage of GlcNAc-1-phosphotransferase precursor protein (GNPTAB).
De Pace R, Coutinho MF, Koch-Nolte F, Haag F, Prata MJ, Alves S, Braulke T, Pohl S., Hum Mutat 35(3), 2014
PMID: 24375680
Systemic accumulation of undigested lysosomal metabolites in an autopsy case of mucolipidosis type II; autophagic dysfunction in cardiomyocyte.
Sato Y, Kobayashi H, Sato S, Shimada Y, Fukuda T, Eto Y, Ohashi T, Ida H., Mol Genet Metab 112(3), 2014
PMID: 24857410
A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology.
Paton L, Bitoun E, Kenyon J, Priestman DA, Oliver PL, Edwards B, Platt FM, Davies KE., J Biol Chem 289(39), 2014
PMID: 25107912
Molecular characterization of arylsulfatase G: expression, processing, glycosylation, transport, and activity.
Kowalewski B, Lübke T, Kollmann K, Braulke T, Reinheckel T, Dierks T, Damme M., J Biol Chem 289(40), 2014
PMID: 25135642
Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV.
Grishchuk Y, Sri S, Rudinskiy N, Ma W, Stember KG, Cottle MW, Sapp E, Difiglia M, Muzikansky A, Betensky RA, Wong AM, Bacskai BJ, Hyman BT, Kelleher RJ, Cooper JD, Slaugenhaupt SA., Acta Neuropathol Commun 2(), 2014
PMID: 25200117
Granule protein processing and regulated secretion in neutrophils.
Sheshachalam A, Srivastava N, Mitchell T, Lacy P, Eitzen G., Front Immunol 5(), 2014
PMID: 25285096
Neurologic abnormalities in mouse models of the lysosomal storage disorders mucolipidosis II and mucolipidosis III γ.
Idol RA, Wozniak DF, Fujiwara H, Yuede CM, Ory DS, Kornfeld S, Vogel P., PLoS One 9(10), 2014
PMID: 25314316
Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.
Kollmann K, Uusi-Rauva K, Scifo E, Tyynelä J, Jalanko A, Braulke T., Biochim Biophys Acta 1832(11), 2013
PMID: 23402926
Glycobiology of cell death: when glycans and lectins govern cell fate.
Lichtenstein RG, Rabinovich GA., Cell Death Differ 20(8), 2013
PMID: 23703323
Ultrastructural analysis of neuronal and non-neuronal lysosomal storage in mucolipidosis type II knock-in mice.
Schweizer M, Markmann S, Braulke T, Kollmann K., Ultrastruct Pathol 37(5), 2013
PMID: 24047352
Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II.
Kollmann K, Pestka JM, Kühn SC, Schöne E, Schweizer M, Karkmann K, Otomo T, Catala-Lehnen P, Failla AV, Marshall RP, Krause M, Santer R, Amling M, Braulke T, Schinke T., EMBO Mol Med 5(12), 2013
PMID: 24127423
A hereditary spastic paraplegia mouse model supports a role of ZFYVE26/SPASTIZIN for the endolysosomal system.
Khundadze M, Kollmann K, Koch N, Biskup C, Nietzsche S, Zimmer G, Hennings JC, Huebner AK, Symmank J, Jahic A, Ilina EI, Karle K, Schöls L, Kessels M, Braulke T, Qualmann B, Kurth I, Beetz C, Hübner CA., PLoS Genet 9(12), 2013
PMID: 24367272

58 References

Daten bereitgestellt von Europe PubMed Central.

Lysosomal disorders: from storage to cellular damage.
Ballabio A, Gieselmann V., Biochim. Biophys. Acta 1793(4), 2008
PMID: 19111581
Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice.
Blanz J, Stroobants S, Lullmann-Rauch R, Morelle W, Ludemann M, D'Hooge R, Reuterwall H, Michalski JC, Fogh J, Andersson C, Saftig P., Hum. Mol. Genet. 17(22), 2008
PMID: 18713755
Vacuolization of mucolipidosis type II mouse exocrine gland cells represents accumulation of autolysosomes.
Boonen M, van Meel E, Oorschot V, Klumperman J, Kornfeld S., Mol. Biol. Cell 22(8), 2011
PMID: 21325625
Spontaneous mucolipidosis in a cat: an animal model of human I-cell disease.
Bosshard NU, Hubler M, Arnold S, Briner J, Spycher MA, Sommerlade HJ, von Figura K, Gitzelmann R., Vet. Pathol. 33(1), 1996
PMID: 8826001
Sorting of lysosomal proteins.
Braulke T, Bonifacino JS., Biochim. Biophys. Acta 1793(4), 2008
PMID: 19046998
Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands.
Cathey SS, Leroy JG, Wood T, Eaves K, Simensen RJ, Kudo M, Stevenson RE, Friez MJ., J. Med. Genet. 47(1), 2009
PMID: 19617216
Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
Claussen M, Kubler B, Wendland M, Neifer K, Schmidt B, Zapf J, Braulke T., Endocrinology 138(9), 1997
PMID: 9275067
The cellular pathology of lysosomal diseases.
Cox TM, Cachon-Gonzalez MB., J. Pathol. 226(2), 2012
PMID: 21990005
Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.
Damme M, Stroobants S, Walkley SU, Lullmann-Rauch R, D'Hooge R, Fogh J, Saftig P, Lubke T, Blanz J., J. Neuropathol. Exp. Neurol. 70(1), 2011
PMID: 21157375
Mice lacking alpha/beta subunits of GlcNAc-1-phosphotransferase exhibit growth retardation, retinal degeneration, and secretory cell lesions.
Gelfman CM, Vogel P, Issa TM, Turner CA, Lee WS, Kornfeld S, Rice DS., Invest. Ophthalmol. Vis. Sci. 48(11), 2007
PMID: 17962477
A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes.
Hickman S, Neufeld EF., Biochem. Biophys. Res. Commun. 49(4), 1972
PMID: 4345092
Cellular uptake of saposin (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor-related protein (LRP).
Hiesberger T, Huttler S, Rohlmann A, Schneider W, Sandhoff K, Herz J., EMBO J. 17(16), 1998
PMID: 9707421
Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis.
Jabs S, Quitsch A, Kakela R, Koch B, Tyynela J, Brade H, Glatzel M, Walkley S, Saftig P, Vanier MT, Braulke T., J. Neurochem. 106(3), 2008
PMID: 18498441
Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury.
Jansen P, Giehl K, Nyengaard JR, Teng K, Lioubinski O, Sjoegaard SS, Breiderhoff T, Gotthardt M, Lin F, Eilers A, Petersen CM, Lewin GR, Hempstead BL, Willnow TE, Nykjaer A., Nat. Neurosci. 10(11), 2007
PMID: 17934455
Lysosomal biogenesis in lysosomal storage disorders.
Karageorgos LE, Isaac EL, Brooks DA, Ravenscroft EM, Davey R, Hopwood JJ, Meikle PJ., Exp. Cell Res. 234(1), 1997
PMID: 9223373
Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport.
Kobayashi T, Beuchat MH, Lindsay M, Frias S, Palmiter RD, Sakuraba H, Parton RG, Gruenberg J., Nat. Cell Biol. 1(2), 1999
PMID: 10559883
Mannose phosphorylation in health and disease.
Kollmann K, Pohl S, Marschner K, Encarnacao M, Sakwa I, Tiede S, Poorthuis BJ, Lubke T, Muller-Loennies S, Storch S, Braulke T., Eur. J. Cell Biol. 89(1), 2009
PMID: 19945768
Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration.
Komatsu M, Wang QJ, Holstein GR, Friedrich VL Jr, Iwata J, Kominami E, Chait BT, Tanaka K, Yue Z., Proc. Natl. Acad. Sci. U.S.A. 104(36), 2007
PMID: 17726112
I-cell disease and pseudo-Hurler polydystrophy: disorders of lysosomal enzyme phosphorylation and localization
Kornfeld S, Sly WS., 2001
The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin.
Lefrancois S, Zeng J, Hassan AJ, Canuel M, Morales CR., EMBO J. 22(24), 2003
PMID: 14657016
Mutant enzymatic and cytological phenotypes in cultured human fibroblasts.
Leroy JG, Demars RI., Science 157(3790), 1967
PMID: 17842782
Proteomics of the lysosome.
Lubke T, Lobel P, Sleat DE., Biochim. Biophys. Acta 1793(4), 2008
PMID: 18977398
A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism.
Marschner K, Kollmann K, Schweizer M, Braulke T, Pohl S., Science 333(6038), 2011
PMID: 21719679
I-cell disease. A further report on its pathology.
Martin JJ, Leroy JG, van Eygen M, Ceuterick C., Acta Neuropathol. 64(3), 1984
PMID: 6093421
Inheritance, biochemical abnormalities, and clinical features of feline mucolipidosis II: the first animal model of human I-cell disease.
Mazrier H, Van Hoeven M, Wang P, Knox VW, Aguirre GD, Holt E, Wiemelt SP, Sleeper MM, Hubler M, Haskins ME, Giger U., J. Hered. 94(5), 2003
PMID: 14557388
Neuropathology of the Mcoln1(-/-) knockout mouse model of mucolipidosis type IV.
Micsenyi MC, Dobrenis K, Stephney G, Pickel J, Vanier MT, Slaugenhaupt SA, Walkley SU., J. Neuropathol. Exp. Neurol. 68(2), 2009
PMID: 19151629
Characterization of the N-linked glycans of Giardia intestinalis.
Morelle W, Jimenez JC, Cieniewski-Bernard C, Dei-Cas E, Michalski JC., Glycobiology 15(5), 2004
PMID: 15616121
Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells.
Nielsen R, Courtoy PJ, Jacobsen C, Dom G, Lima WR, Jadot M, Willnow TE, Devuyst O, Christensen EI., Proc. Natl. Acad. Sci. U.S.A. 104(13), 2007
PMID: 17369355
Neuronal localization and association of Niemann Pick C2 protein (HE1/NPC2) with the postsynaptic density.
Ong WY, Sundaram RK, Huang E, Ghoshal S, Kumar U, Pentchev PG, Patel SC., Neuroscience 128(3), 2004
PMID: 15381285
Excessive activity of cathepsin K is associated with cartilage defects in a zebrafish model of mucolipidosis II.
Petrey AC, Flanagan-Steet H, Johnson S, Fan X, De la Rosa M, Haskins ME, Nairn AV, Moremen KW, Steet R., Dis Model Mech 5(2), 2011
PMID: 22046029
Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC)
Raas-Rothschild A, Cormier-Daire V, Bao M, Genin E, Salomon R, Brewer K, Zeigler M, Mandel H, Toth S, Roe B, Munnich A, Canfield WM., J. Clin. Invest. 105(5), 2000
PMID: 10712439
LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.
Reczek D, Schwake M, Schroder J, Hughes H, Blanz J, Jin X, Brondyk W, Van Patten S, Edmunds T, Saftig P., Cell 131(4), 2007
PMID: 18022370
Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study.
Roces DP, Lullmann-Rauch R, Peng J, Balducci C, Andersson C, Tollersrud O, Fogh J, Orlacchio A, Beccari T, Saftig P, von Figura K., Hum. Mol. Genet. 13(18), 2004
PMID: 15269179
High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP.
Rodriguez CI, Buchholz F, Galloway J, Sequerra R, Kasper J, Ayala R, Stewart AF, Dymecki SM., Nat. Genet. 25(2), 2000
PMID: 10835623
Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation.
Schulze H, Kolter T, Sandhoff K., Biochim. Biophys. Acta 1793(4), 2008
PMID: 19014978
Identification of sites of mannose 6-phosphorylation on lysosomal proteins.
Sleat DE, Zheng H, Qian M, Lobel P., Mol. Cell Proteomics 5(4), 2006
PMID: 16399764
The genetic mucolipidoses. Diagnosis and differential diagnosis.
Spranger JW, Wiedemann HR., Humangenetik 9(2), 1970
PMID: 4246487
Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase.
Tiede S, Storch S, Lubke T, Henrissat B, Bargal R, Raas-Rothschild A, Braulke T., Nat. Med. 11(10), 2005
PMID: 16200072
Clinical, biochemical, and ultrastructural studies in a case of chondrodystrophy presenting the I-cell phenotype in tissue culture.
Tondeur M, Vamos-Hurwitz E, Mockel-Pohl S, Dereume JP, Cremer N, Loeb H., J. Pediatr. 79(3), 1971
PMID: 4327937
Comparative pathology of murine mucolipidosis types II and IIIC.
Vogel P, Payne BJ, Read R, Lee WS, Gelfman CM, Kornfeld S., Vet. Pathol. 46(2), 2009
PMID: 19261645
Deficiency of UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase in organs of I-cell patients.
Waheed A, Pohlmann R, Hasilik A, von Figura K, van Elsen A, Leroy JG., Biochem. Biophys. Res. Commun. 105(3), 1982
PMID: 6212058
Lysosomal compromise and brain dysfunction: examining the role of neuroaxonal dystrophy.
Walkley SU, Sikora J, Micsenyi M, Davidson C, Dobrenis K., Biochem. Soc. Trans. 38(6), 2010
PMID: 21118103
Secondary lipid accumulation in lysosomal disease.
Walkley SU, Vanier MT., Biochim. Biophys. Acta 1793(4), 2008
PMID: 19111580
Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl- accumulation.
Weinert S, Jabs S, Supanchart C, Schweizer M, Gimber N, Richter M, Rademann J, Stauber T, Kornak U, Jentsch TJ., Science 328(5984), 2010
PMID: 20430974
Nucleolin: acharan sulfate-binding protein on the surface of cancer cells.
Joo EJ, ten Dam GB, van Kuppevelt TH, Toida T, Linhardt RJ, Kim YS., Glycobiology 15(1), 2004
PMID: 15329357

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

PMID: 22961545
PubMed | Europe PMC

Suchen in

Google Scholar